A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma | MicrobiomeTrials
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-02-11Est. Completion: 2028-11
Enrollment target: 130 participants
Locations
Arizona Advanced Eye Research Institute /ID# 268363, Glendale, Arizona, United States
LA Glaucoma Group /ID# 268444, Culver City, California, United States
North Bay Eye Associates /ID# 277071, Petaluma, California, United States
University Of Colorado - Anschutz Medical Campus /ID# 269947, Aurora, Colorado, United States
Colorado Eye Institute /ID# 277072, Colorado Springs, Colorado, United States
Eye Center of Northern Colorado /ID# 281798, Fort Collins, Colorado, United States
Brandon Eye Associates - Brandon /ID# 277074, Brandon, Florida, United States
New Vision Eye Center /ID# 269955, Vero Beach, Florida, United States
Coastal Research Associates - Roswell /ID# 268458, Roswell, Georgia, United States
Illinois Eye Center - Peoria Location /ID# 277127, Peoria, Illinois, United States
Stiles Eyecare Excellence & Glaucoma Institute /ID# 268451, Overland Park, Kansas, United States
Tulane Center for Clinical Research /ID# 277486, New Orleans, Louisiana, United States
Minnesota Eye Consultants - Minneapolis /ID# 272445, Minneapolis, Minnesota, United States
Vance Thompson Vision - Omaha /ID# 271599, Omaha, Nebraska, United States
Other microbiome trials you might be interested in